AI in Medical Diagnostics companies globally

Developer of a screening platform for circulating tumor DNA to detect cancer. The company is developing a test called "Galleri" a pan-cancer screening test by measuring circulating nucleic acids in the blood. Its proprietary platform uses the ultra-deep sequencing technique to measure levels of circulating tumor DNA in the patient's blood.

AI-based precision medicine solutions for oncology. It provide an informatics platform for cancer treatment that helps physicians to make decisions based on computational analysis of a patient’s pathology. The platform analyzes a patient’s genetic data in the context of molecular therapies. The company connects bioinformatics with anatomical pathology providing doctors with relevant insight to make oncological decisions and more.

Portable ultrasound system for external ultrasound imaging. The company offer a handheld portable ultrasound machine that is powered by Ultrasound-on-Chip technology, which is the world's only single-probe, whole-body handheld device for various clinical applications such as procedural guidance, fetal or obstetric treatment, cardiac, peripheral vessels, urology, and ophthalmic treatments.

Provider of solutions for biomarker discovery, diagnostic tests, and personalized medicine. It offers a biochemical profiling platform that analyzes and identifies biochemicals in the research of pharmaceutical, biotech, agriculture, cosmetic, and consumer products. It also offers Quantose IR, a lab test for prediabetes assessment and treatment, and Meta IMD, a CLIA assay for inborn errors of metabolism. The company is also developing metabolomics-based clinical diagnostic tests that may improve the early detection of obesity-related metabolic diseases.